Skip to main content

Together we are beating cancer

Donate now

Cancer News

Cancer Research UK-funded research

Showing 12 out of 968 results

We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…    We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…   

by Phil Prime | In depth | 10 March 2023

10 March 2023

Colourful icons showing a diverse group of people

One year on from signing up to the Shared Commitment to Patient Involvement, we’re reflecting on our successes in involving people affected by cancer in research, but also on where we strive to do better. One year on from signing up to the Shared Commitment to Patient Involvement, we’re reflecting on our successes in involving people affected by cancer in research, but also on where we strive to do better.

by Anne-Sophie Kleczewski, Jane Oakley | Analysis | 10 March 2023

10 March 2023

A Cancer Grand Challenges graphic announcing 9 new challenges
  • Health & Medicine
  • Science & Technology

Time to take on 9 new Cancer Grand Challenges

These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them. These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.

by Tim Gunn | News | 8 March 2023

8 March 2023

A breast cancer cell seen through a special microscope.
  • Science & Technology

Can cancer cells communicate?

Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too. Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too.

by Tim Gunn | Analysis | 28 February 2023

28 February 2023

A cancer cell undergoing mitosis, or cloning itself and splitting in two.

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it. Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it.

by Tim Gunn | In depth | 20 February 2023

20 February 2023

In this episode I tease out four themes that emerged over this first series that give some interesting insights into how we work as scientists, research leaders and research translators. It features some of the fantastic researchers that we have interviewed over the past year – including Professor Steve Jackson, Professor Ruth Plummer, Dr Simon Boulton, Professor Sir Leszek Borysiewicz, Professor Karen Vousden, Professor Richard Gilbertson and Professor Charles Swanton. In this episode I tease out four themes that emerged over this first series that give some interesting insights into how we work as scientists, research leaders and research translators. It features some of the fantastic researchers that we have interviewed over the past year – including Professor Steve Jackson, Professor Ruth Plummer, Dr Simon Boulton, Professor Sir Leszek Borysiewicz, Professor Karen Vousden, Professor Richard Gilbertson and Professor Charles Swanton.

by Phil Prime | Podcast | 14 February 2023

14 February 2023

This entry is part 9 of 9 in the series Cancer Research Matters - series 1
Glioblastoma cells seen through a microscope.

We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective. We've helped double brain tumour survival over the past 40 years. Now, researchers are combining some of our most successful drugs, temozolomide and PARP inhibitors, to make glioblastoma treatment more effective.

by Tim Gunn | Analysis | 13 February 2023

13 February 2023

We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily. We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily.

by Cancer Research UK | In depth | 10 February 2023

10 February 2023

Restricting cancer cells of specific amino acids can slow tumour growth and sharpen the effects of chemotherapy and radiotherapy – now, startup Faeth Therapeutics is creating precision diets which can enhance cancer treatments. Restricting cancer cells of specific amino acids can slow tumour growth and sharpen the effects of chemotherapy and radiotherapy – now, startup Faeth Therapeutics is creating precision diets which can enhance cancer treatments.

by Cancer Research UK | In depth | 30 January 2023

30 January 2023

In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research. In a new series focussing on research integrity, two of our experts will dig into the issues and challenges of this incredibly important aspect of research.

by Cancer Research UK | Analysis | 24 January 2023

24 January 2023

This entry is part 5 of 16 in the series Research Integrity